Fundacio Hospital Sant Joan De Deu De Martorell
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses
The research program at Fundacio Hospital Sant Joan De Deu De Martorell is dedicated to advancing care for serious fungal lung diseases, with a particular focus on chronic pulmonary aspergillosis.
- Evaluation of extended‑duration antifungal therapy
- Assessment of clinical and radiological outcomes using validated tools
- Exploration of treatment options for patients with limited alternatives
Ongoing studies aim to determine the effectiveness of new agents such as rezafungin in improving symptoms, weight, and imaging findings for affected adults.
Respiratory Tract Diseases
Investigations at the centre address chronic airway disorders, especially bronchiectasis, where bacterial colonisation poses a major challenge.
- Comparison of multiple antibiotic regimens against placebo
- Measurement of microbiological eradication of Pseudomonas aeruginosa
- Evaluation of quality‑of‑life impact through patient‑reported outcomes
The goal is to identify strategies that reliably clear infection and reduce disease burden for adults with non‑cystic fibrosis bronchiectasis.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fundacio Hospital Sant Joan De Deu De Martorell
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Rezafungin Acetate for Chronic Pulmonary Aspergillosis in Patients with Limited Treatment Options: A Phase 2, Open-Label Study | Mundipharma Research Limited | Phase II | Not Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ciprofloxacin | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.